Sep 13, 2010 . Jennerex Inc., San Francisco, Calif. Transgene S.A. (Euronext:TNG), Illkirch,

Mar 20, 2012 . Regulatory News: Jennerex, Inc., a private clinical-stage biotherapeutics

Transgene Jennerex Results, websites with the topic transgene jennerex results.www.webmator.com/transgene/transgene%20jennerex%20results - CachedTwitter / Cancer News Network: Jennerex, Transgene Join F . Jennerex, Transgene Join Forces To Fight Against Cancer http://sns.ly/2SN49 #

Apr 5, 2011 . Jennerex and Transgene Announce the Presentation of Positive Clinical Data of

Mar 20, 2012 . Transgene and Jennerex Announce First Patient Treated in Phase 1/2 Clinical

Apr 5, 2011 . EASL: Jennerex and Transgene Announce the Presentation of Positive Clinical

Mar 20, 2012 . Transgene and Jennerex Announce First Patient Treated in Phase 1/2 Clinical

Jennerex Inc. a private clinical-stage biotherapeutics corporation focused on the

Dec 21, 2011 . Regulatory News: Product to be used as neoadjuvant therapy to patients

Dec 28, 2011 . Pharmacy Choice - Pharmaceutical News - Transgene and Jennerex initiate

Apr 21, 2012 . ennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in

Jennerex and Transgene initiate Phase I/II colorectal cancer trial. Jennerex, Inc.,

Apr 5, 2011 . Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the

Apr 7, 2011 . Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the

Apr 6, 2011 . Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver .

Jennerex reports positive proof-of-concept in clinical trial to treat metastatic

Sep 9, 2010 . US privately-held oncology-focussed drug developer Jennerex has entered into

Dec 16, 2010 . Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-

Sep 8, 2010 . France's Transgene is hitching its wagon and a $116 million slate of milestones

20 mars 2012 . Regulatory News: Transgene (Paris:TNG) (NYSE Euronext Paris :

Read Blog Posts about Jennerex And Transgene at Regator.regator.com/whatshot/Jennerex+And+Transgene/Jennerex Announces Data Presentations Relating to Oncolytic Virus . May 16, 2012 . About Jennerex's Partners for JX-594. Transgene (NYSE Euronext Paris:

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX

Sep 8, 2010 . A partnership between the U.S. company Jennerex Inc. known for developing

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the

Apr 4, 2011 . We look forward to reporting additional clinical results in patients . ,Jennerex,and

Mar 20, 2012 . Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of .

Dec 21, 2011 . Transgene and Jennerex Announce First Patient Treated in Phase 2a. Clinical

Apr 5, 2011 . SAN FRANCISCO and ILLKIRCH, France, April 5, 2011 /NEWS.GNOM.ES/ --

Your position: health diseases -> News -> Jennerex Transgene present JX-594

Nov 14, 2011 . TRANSGENE : and Jennerex Announce Final Data at AASLD From JX594/

Feb 7, 2012 . Jennerex Publishes Data on JX-594 Cancer Targeting Mechanisms . Transgene

Sep 7, 2010 . Jennerex and Transgene Enter into an Exclusive Partnership for the

05.04 08:12 Jennerex, Transgene present JX-594 Phase 1 and 2 study data in

Firms plan Phase III study in hepatocellular carcinoma and Phase II colorectal

Apr 5, 2011 . SAN FRANCISCO and ILLKIRCH, Jennerex, Inc., a private clinical-stage

Press Releases. Jennerex and Transgene Announce Initiation of Clinical Trial of

Nov 7, 2011 . Transgene and Jennerex Announce Final Data at AASLD From JX594/TG6006

May 19, 2011 . Regulatory News: Jennerex Biotherapeutics, Inc., a private clinical-stage

Sep 8, 2010 . France's Transgene is hitching its wagon and a $116 million slate of milestones

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the

Apr 5, 2012 . Jennerex and Transgene announced the presentation of data from phase 1 to

Nov 4, 2011 . The TRAVERSE Study Should Recruit 120 Patients in 45 Sites Globally . |

Apr 6, 2011 . SAN FRANCISCO and ILLKIRCH, France, April 6, 2011 /PRNewswire/ --

Sep 8, 2010 . Jennerex and Transgene Enter Into an Exclusive Partnership for the

Apr 6, 2011 . Jennerex and Transgene Announce Presentation of Phase 1 Data

Nov 7, 2011 . Transgene SA and Jennerex Biotherapeutics said the high doses of their JX594/

Jennerex is a clinical-stage biotherapeutics company focused on the . Together,

Transgene announced Wednesday an exclusive partnership with the American

Sitemap